Huang, Tao
Hu, Qianqian
Zhou, Xiang
Yang, Huaiyu
Xia, Wei
Cao, Feng
Deng, Minglu
Teng, Xiaoxue
Ding, Fan
Zhong, Zaixin
Gao, Lidong
Sun, Jiufeng
Gong, Lihui
Article History
Received: 25 July 2023
Accepted: 4 April 2024
First Online: 19 April 2024
Declarations
:
: The trial was approved with the written consent procedure to be followed by the Institutional Research Ethics review Board (IRB) in Hunan Provincial Center for Disease Control. The trial was approved by the ClinicalTrials.gov No. NCT05895110. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Written informed consent was obtained from all patients for being included in the study.
: The authors declare no competing interests.